Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma

Clinical trial NCT06383728 · RECRUITING

Trial details

NCT number: NCT06383728
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Carcinoma, Squamous Cell

Start date: 2024-04-01
Primary completion: 2025-10-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.